<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
PFE
Pfizer
$
()


  • Interpublic losing out in Pfizer reshuffle 'disappointing,' says BofA

    3/28/2024 - 15:43pm
  • Pfizer shifts most creative duties to Publicis from Interpublic, AdAge reports

    3/28/2024 - 15:38pm
  • Pieris Pharmaceuticals to discontinue all R&D efforts, reduce workforce, board

    3/27/2024 - 08:27am
  • Notable open interest changes for March 25th

    3/25/2024 - 08:56am
  • Best Buy upgraded, Nike downgraded: Wall Street's top analyst calls

    3/22/2024 - 09:41am
  • Argus cuts Pfizer to Hold on headwinds to revenue growth

    3/22/2024 - 07:30am
  • Argus gets more bearish on Pfizer, downgrades shares

    3/22/2024 - 06:59am
  • Pfizer price target lowered by $3 at Guggenheim, here's why

    3/22/2024 - 06:52am
  • Puma Biotechnology says court denied AstraZeneca's motion for invalidity

    3/19/2024 - 22:17pm
  • Haleon files to sell 630M ordinary shares for holders

    3/18/2024 - 16:01pm
  • Pfizer announces EC grants marketing authorization for Prevenar 20

    3/13/2024 - 05:14am
  • Oric Pharmaceuticals price target raised by $3 at Oppenheimer, here's why

    3/12/2024 - 08:35am
  • Pfizer's Adcetris shows improved survival in Phase 3 lymphoma trial

    3/12/2024 - 06:47am
  • FDA approves Pfizer's inotuzumab ozogamicin for pediatric ALL patients

    3/6/2024 - 14:58pm
  • ViiV Healthcare announces interim data of LATITUDE phase III trial

    3/6/2024 - 12:11pm
dynamic_feed Breaking News